Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Feb 1, 2025 | (Q4)Feb 1, 2025 | (Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -13.80%430.65M | -10.84%363.54M | 60.48%-30.58M | -15.15%71.26M | -69.00%26.44M | 58.65%499.62M | 13.29%407.73M | 15.10%-77.38M | 1,978.64%83.98M | 102.51%85.29M |
Net income from continuing operations | -15.77%253.61M | -7.29%187.46M | -88.44%1.69M | -29.54%33M | -16.04%31.47M | 15.13%301.11M | 18.02%202.2M | -9.61%14.59M | 13.28%46.84M | 14.55%37.48M |
Depreciation and amortization | 28.07%167.45M | 22.70%45.51M | 28.87%43.28M | 34.28%41.47M | 27.40%37.18M | 23.79%130.75M | 28.27%37.1M | 21.78%33.58M | 22.83%30.88M | 21.72%29.19M |
Deferred tax | -190.25%-6.85M | -253.60%-8.26M | -211.41%-1.33M | 369.29%2.86M | -129.13%-120K | -66.98%7.59M | -69.73%5.38M | 3,411.11%1.19M | -82.87%609K | -75.81%412K |
Other non cash items | 273.79%1.31M | 151.96%451K | 565.00%665K | 111.11%76K | 233.33%120K | -14.18%351K | 297.78%179K | 20.48%100K | -95.11%36K | 107.91%36K |
Change In working capital | -101.09%-459K | -15.34%134.09M | 37.63%-81.46M | -2,427.83%-5.81M | -427.85%-47.27M | 142.30%41.96M | 16.13%158.39M | 7.29%-130.61M | 99.68%-230K | 166.07%14.42M |
-Change in inventory | -31.57%-74.87M | -11.41%158.33M | 19.01%-177.95M | -7.24%-9.9M | -580.07%-45.35M | 21.63%-56.91M | 2.81%178.72M | -66.01%-219.73M | 85.80%-9.23M | 86.41%-6.67M |
-Change in prepaid assets | 67.44%-7.35M | 203.96%15.05M | 17.21%-26.95M | 72.40%-1.84M | -45.34%6.39M | 38.87%-22.59M | 549.68%4.95M | -93.35%-32.56M | 78.25%-6.68M | 0.03%11.7M |
-Change in payables and accrued expense | -48.71%35.88M | 8.59%-39.27M | 6.25%115.41M | -643.55%-10.31M | -627.53%-29.95M | 455.76%69.94M | -9.86%-42.96M | 6,154.29%108.61M | -113.84%-1.39M | -49.41%5.68M |
-Change in other working capital | -10.92%45.89M | -100.13%-23K | -38.46%8.04M | -4.83%16.24M | 482.24%21.64M | 71.59%51.52M | 542.46%17.67M | 29.25%13.06M | 33.06%17.07M | -14.40%3.72M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -13.80%430.65M | -10.84%363.54M | 60.48%-30.58M | -15.15%71.26M | -69.00%26.44M | 58.65%499.62M | 13.29%407.73M | 15.10%-77.38M | 1,978.64%83.98M | 102.51%85.29M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 58.13%-232.94M | 48.30%-202.27M | 36.83%-8.65M | 160.13%51.06M | -9.91%-73.08M | -14,020.18%-556.34M | -439.76%-391.26M | 29.04%-13.69M | -379.40%-84.9M | -215.74%-66.49M |
Capital expenditure reported | 3.30%-323.99M | 49.44%-52.14M | 30.40%-80.38M | -45.24%-103.61M | -94.86%-87.87M | -32.98%-335.05M | -31.60%-103.13M | -80.81%-115.5M | -38.19%-71.33M | 22.38%-45.09M |
Net investment purchase and sale | 141.15%91.06M | 47.89%-150.13M | -29.54%71.74M | 1,239.57%154.66M | 169.12%14.79M | -189.22%-221.29M | -5,001.84%-288.13M | 128.32%101.81M | -116.55%-13.57M | -118.52%-21.4M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 58.13%-232.94M | 48.30%-202.27M | 36.83%-8.65M | 160.13%51.06M | -9.91%-73.08M | -14,020.18%-556.34M | -439.76%-391.26M | 29.04%-13.69M | -379.40%-84.9M | -215.74%-66.49M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 52.28%-45.74M | 115.47%752K | 99.86%-111K | -5,278.38%-9.58M | -132.31%-36.8M | -119.68%-95.86M | -48.22%349K | -17,920.36%-80.55M | 7.56%185K | 64.02%-15.84M |
Net common stock issuance | 52.07%-46.08M | 18.34%413K | 99.86%-111K | -3.32%-16.23M | ---30.15M | -117.70%-96.15M | 4,262.50%349K | -38,738.94%-80.79M | -297.04%-15.71M | --0 |
Proceeds from stock option exercised by employees | 18.06%340K | --339K | --0 | --0 | -96.15%1K | -62.93%288K | --0 | 2,500.00%234K | 27.27%28K | -67.50%26K |
Net other financing activities | ---- | ---- | ---- | ---- | 58.08%-6.65M | ---- | ---- | ---- | ---- | -286.36%-15.87M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 52.28%-45.74M | 115.47%752K | 99.86%-111K | -5,278.38%-9.58M | -132.31%-36.8M | -119.68%-95.86M | -48.22%349K | -17,920.36%-80.55M | 7.56%185K | 64.02%-15.84M |
Net cash flow | ||||||||||
Beginning cash position | -45.91%179.75M | 4.16%169.7M | -37.52%209.04M | -71.28%96.31M | -45.91%179.75M | 411.48%332.32M | 268.37%162.93M | 115.69%334.54M | 178.24%335.29M | 411.48%332.32M |
Current changes in cash | 199.60%151.97M | 863.18%162.02M | 77.08%-39.34M | 15,292.86%112.73M | -2,917.05%-83.44M | -157.07%-152.58M | -94.16%16.82M | -54.79%-171.62M | -102.14%-742K | -94.67%2.96M |
End cash Position | 84.55%331.72M | 84.55%331.72M | 4.16%169.7M | -37.52%209.04M | -71.28%96.31M | -45.91%179.75M | -45.91%179.75M | 268.37%162.93M | 115.69%334.54M | 178.24%335.29M |
Free cash flow | -35.19%106.65M | 2.23%311.4M | 42.47%-110.96M | -355.84%-32.35M | -252.80%-61.43M | 161.34%164.57M | 8.19%304.6M | -24.42%-192.88M | 126.58%12.65M | 351.66%40.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |